MARKET

SAVA

SAVA

Cassava Sciences Inc
NASDAQ
24.48
+0.47
+1.96%
After Hours: 24.50 +0.02 +0.08% 17:06 06/08 EDT
OPEN
24.06
PREV CLOSE
24.01
HIGH
25.17
LOW
23.53
VOLUME
713.30K
TURNOVER
0
52 WEEK HIGH
51.59
52 WEEK LOW
13.84
MARKET CAP
1.02B
P/E (TTM)
-12.0029
1D
5D
1M
3M
1Y
5Y
Noteworthy Thursday Option Activity: SAVA, SMG, HAS
NASDAQ · 2h ago
Cassava (SAVA) Up on Progress With Alzheimers Disease Study
NASDAQ · 05/30 16:06
Cassava Sciences: State Of Play After Earnings - 5 Things To Note
Seeking Alpha · 05/23 21:06
Unusual Put Option Trade in Cassava Sciences (SAVA) Worth $338.07K
NASDAQ · 05/18 22:37
Notable Thursday Option Activity: U, SAVA, MCD
NASDAQ · 05/18 19:21
These stocks are seeing some short squeeze action - watch out above
Seeking Alpha · 05/18 14:59
Cassava Sciences' Simufilam, Anavex's Blarcamesine, And Aricept: Shared Mechanisms Of Action In The Treatment Of Alzheimer's Disease
Seeking Alpha · 05/16 18:56
Biogen’s new Alzheimer’s drug to raise annual Medicare costs by up to $5B – study
Seeking Alpha · 05/14 16:00
More
About SAVA
Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is engaged in the detection and treatment of neurodegenerative diseases, such as Alzheimer’s disease. The Company develops pharmaceutical product candidates that offer improvements to patients and healthcare professionals. The Company has two biopharmaceutical assets under development, including its lead therapeutic product candidate, called simufilam, is an oral treatment for Alzheimer’s disease dementia, which is under Phase III clinical studies; and its lead investigational diagnostic product candidate, called SavaDx, is a way to detect the presence of Alzheimer’s disease from a small sample of blood. Simufilam is a proprietary small molecule (oral) drug, which targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. SavaDx is designed as an antibody-based detection system for altered filamin A (FLNA).

Webull offers kinds of Cassava Sciences Inc stock information, including NASDAQ:SAVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SAVA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SAVA stock methods without spending real money on the virtual paper trading platform.